W006 Hands-on: Lasers
DESCRIPTION
Tuition fee and ticket required for admission
This session is geared toward all levels of dermatologists, from beginner and intermediate to advanced levels. It offers small groups, hands-on experience practicing a variety of laser skills and techniques. Approaches to patient assessment and selection, treatment planning, equipment selection, laser safety, and proper application of devices will be covered. Small groups will rotate between stations demonstrating ablative resurfacing, nonablative rejuvenation, tattoo and pigment removal, acne and vascular lesions, skin tightening, fat melting, and body contouring. Participants will complete a pre- and post-assessment of procedural skills covered in this session.
This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
**Please register for only one Hands-on: Lasers workshop. Both workshops present the same content.**
LEARNING OBJECTIVES
Discuss current indications and treatment protocols for energy-based device treatments including vascular, tattoo, pigment, non-ablative, fractional, and ablative lasers.
Identify appropriate patients and gain treatment pearls for skin tightening, fat melting, and body contouring procedures.
Utilize proper laser techniques, and treat a variety of dermatologic conditions with laser and light devices.
SCHEDULE
4:00 PM
Hands-On Lasers
SPEAKERS
Michael Abrouk, MD
Mathew M Avram, MD, JD, FAAD
Ashish Bhatia, MD, FAAD
Amanda Hope Champlain, MD, FAAD
Rishi Chopra, MD, MS, FAAD
Joel Lee Cohen, MD, FAAD
Catherine M DiGiorgio, MS, MD, FAAD
Omar Ibrahimi, MD, PhD, FAAD
H. Ray Jalian, MD
Yakir S Levin, MD, PhD, FAAD
Morgan BriAnne Murphrey, MD, MS, FAAD
Oge C Onwudiwe, MD, FAAD
Ashaki Patel, MD, FAAD
Hyemin Pomerantz, MD, FAAD
Patricia Richey, MD, FAAD
Thomas E. Rohrer, MD, FAAD
Jennifer Sawaya, MD, FAAD
Sandy Sharon Tsao, MD, FAAD
Aria Vazirnia, MD, FAAD
Molly Wanner, MD, FAAD
Ramone F Williams, MPhil, MD, FAAD
Adam Wulkan, MD
SPEAKER DISCLOSURES
Michael Abrouk, MD
AbbVie – Investigator(Salary); Croma-Pharma GmbH Austria – Investigator(Fees); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Evolus, Inc. – Investigator(Grants/Research Funding); Galderma – Investigator(Fees); Hydrafacial – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Fees);
Mathew M Avram, MD, JD, FAAD
Allergan, Inc – Consultant (1099 relationship)(Fees); Cytrellis Biosystems, Inc – Consultant(Stock), Consultant(Stock Options); La Jolla NanoMedical – Consultant (1099 relationship)(Stock Options); Masters of Aesthetics, Inc. – Founder(Fees); Sofwave – Consultant (1099 relationship)(Stock Options);
Ashish Bhatia, MD, FAAD
AbbVie – Other(Grants/Research Funding), Stockholder Public Company(Stock Options); Alastin Skincare, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Fees), Stockholder Public Company(Stock); BioMarck Pharmaceuticals, Ltd. – Advisory Board(No Compensation Received), Board of Directors(Honoraria), Stockholder(No Compensation Received); Carpe – Consultant (1099 relationship)(Fees), Stockholder Private Company(Stock Options); Cutera, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria), Stockholder(Stock); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant(Honoraria); Derm Education Foundation – Advisory Board(Honoraria), Speaker(Honoraria); Derm.md, Inc. – Board of Directors(No Compensation Received), Stockholder(No Compensation Received); Elsevier Inc. – Consultant(Honoraria); Emblation, Ltd. – Consultant (1099 relationship)(Fees); Endo Pharmaceuticals – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Envy Medical, Inc. – Board of Directors(Fees), Speaker(Honoraria); Evolus, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); GenZum Life Sciences – Stockholder(No Compensation Received); Glo-Pharma, Inc. – Consultant (1099 relationship)(Fees); Medline Industries, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); MiMedx Group, Inc – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Novascan – Other(Grants/Research Funding); Obagi Medical – Consultant (1099 relationship)(Fees); Obagi Medical Products – Consultant (1099 relationship)(Fees); Ortho Dermatologics – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Ourself – Consultant (1099 relationship)(Fees); Paradigm Medical Communications, LLC – Speaker(Honoraria); Pulse Biosciences – Other(Grants/Research Funding); R2 Technologies – Other(Grants/Research Funding); RBC Consultants – Consultant (1099 relationship)(Fees); Revance Therapeutics, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); SimSkin – Advisory Board(Honoraria), Stockholder(No Compensation Received); SofWave – Consultant (1099 relationship)(Fees); Solta Medical – Advisory Board(Honoraria), Consultant(Honoraria); Strata Skin Sciences – Advisory Board(Honoraria), Stockholder Public Company(Stock Options); Theravant Corporation – Advisory Board(Honoraria), Board of Directors(No Compensation Received), Speaker(Honoraria), Stockholder(No Compensation Received); Zalea, LLC – Advisory Board(Honoraria), Consultant(Honoraria);
Amanda Hope Champlain, MD, FAAD
No financial relationships exist with ineligible companies.
Rishi Chopra, MD, MS, FAAD
Accure, Inc – Consultant(Fees); Cynosure – Consultant (1099 relationship)(Equipment); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria);
Joel Lee Cohen, MD, FAAD
Accure Medical, LLC – Investigator(Stock Options); Allergan, Inc. – Consultant(Honoraria); Brickell Biotech, Inc. – Investigator(Grants/Research Funding); BTL Industries – Investigator(Grants/Research Funding); Ferndale Laboratories, Inc. – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria), Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Consultant(Honoraria); Pulse Biosciences – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Sciton Inc. – Consultant(Honoraria);
Catherine M DiGiorgio, MS, MD, FAAD
Acclaro Medical – Other(Equipment); Quthero, Inc – Advisory Board(Stock Options), Investigator(Honoraria); Revelle Aesthetics, Inc. – Consultant(No Compensation Received);
Omar Ibrahimi, MD, PhD, FAAD
AbbVie – Stockholder(Stock); Accure, Inc – Advisory Board(No Compensation Received); Acure Acne – Stockholder(Stock); Allergan, Inc – Advisory Board(Honoraria); AVAVA, LLC – Investigator(Grants/Research Funding), Stockholder(Stock); Beam Therapeutics – Stockholder(Stock); ChromaDex Corp. – Stockholder(Stock); CRISPR Therapeutics – Stockholder(Stock); Cutera, Inc. – Speaker(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria); Editas Medicine – Stockholder(Stock); General Electric – Stockholder(Stock); Gingko Bioworks Holding Inc – Stockholder(Stock); Intellia Therapeutics – Stockholder(Stock); Lutronic – Advisory Board(Honoraria); Moderna Therapeutics – Stockholder(Stock); Pfizer Inc. – Stockholder(Stock); Procter & Gamble Company – Stockholder(Stock); Regeneron Pharmaceuticals, Inc. – Stockholder(Stock); Revance Therapeutics, Inc. – Stockholder(Stock); Soltego – Stockholder(Stock); Unilever – Stockholder(Stock); Vertex Pharmaceuticals, Inc. – Stockholder(Stock); Viatris Inc. – Stockholder(Stock);
H. Ray Jalian, MD
AbbVie – Investigator(Grants/Research Funding); Accure Medical, LLC – Stockholder(Stock); Bausch & Lomb (HK) Ltd. – Speaker(Fees); Candesant Biomedical, Inc. – Advisory Board(Fees); Cytrellis Biosystems, Inc – Advisory Board(Fees); Galderma – Investigator(Fees); Zeltiq Aesthetics – Consultant(Fees);
Yakir S Levin, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Morgan BriAnne Murphrey, MD, MS, FAAD
No financial relationships exist with ineligible companies.
Oge C Onwudiwe, MD, FAAD
No financial relationships exist with ineligible companies.
Ashaki Patel, MD, FAAD
No financial relationships exist with ineligible companies.
Hyemin Pomerantz, MD, FAAD
Acure Acne – Consultant(Fees); American Society of Dermatologic Surgery – Investigator(Grants/Research Funding); AVAVA, LLC – Consultant(Fees); Benev – Consultant (1099 relationship)(Honoraria); Blossom Innovations, LLC – Consultant(Fees); Elsevier Inc. – Other(Fees);
Patricia Richey, MD, FAAD
No financial relationships exist with ineligible companies.
Thomas E. Rohrer, MD, FAAD
Candela Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Lumenis – Investigator(Grants/Research Funding); ultraclear – Advisory Board(Fees); UpToDate – Other(Honoraria);
Jennifer Sawaya, MD, FAAD
No financial relationships exist with ineligible companies.
Sandy Sharon Tsao, MD, FAAD
Epiphany Dermatology – Advisory Board(Stock); Lazarus AI – Consultant(Honoraria); Oncobay – Consultant(Honoraria); Oncobay Clinical – Consultant(Honoraria); UpToDate – Other(Honoraria); WorldCare Clinical LLC – Consultant (1099 relationship)(Honoraria);
Aria Vazirnia, MD, FAAD
No financial relationships exist with ineligible companies.
Molly Wanner, MD, FAAD
3WMN Ventures LLC – Stockholder Private Company(Stock); Bausch Health – Investigator(Grants/Research Funding); Clarity Cosmetics, Inc. – Stockholder(Stock Options); EllaOla – Consultant(Stock Options); Lightwater Biosciences, Inc. – Other(Stock Options); MK2002LLC – Stockholder Private Company(Stock); Nuskin – Advisory Board(Fees), Consultant(Fees); Sorette – Advisory Board(Stock);
Ramone F Williams, MPhil, MD, FAAD
No financial relationships exist with ineligible companies.
Adam Wulkan, MD
No financial relationships exist with ineligible companies.